2024-09-24 - Analysis Report
## Merck & Co Inc. (MRK) Stock Analysis Report

**Company Overview:**  Merck & Co. Inc. is a global pharmaceutical company known for its diverse portfolio of prescription medicines, vaccines, and animal health products.

**Performance Analysis:**

1. **Performance vs. S&P 500:**

   * **Cumulative return:** MRK (82.41%) lagged behind the S&P 500 (VOO) (132.53%) resulting in a significant performance gap. 
   * **Relative divergence:** The current divergence is -50.12%, which represents 33.52% of the historical divergence range. This indicates that MRK has underperformed the S&P 500 relative to its historical performance range. 

2. **Recent Price Movements:**

   * **Closing price:** $117.17 
   * **5-day Moving Average:** $117.84
   * **20-day Moving Average:** $116.86
   * **60-day Moving Average:** $119.52 
   * **Analysis:** MRK's price is currently trading below its 5-day and 60-day moving averages, indicating short-term weakness. However, it's above the 20-day moving average, suggesting a potential for a short-term rebound. 

3. **Technical Indicators:**

   * **RSI:** 45.66 -  This indicates that the stock is currently in neutral territory, neither overbought nor oversold.
   * **PPO:** 0.26 - This suggests a potential for a short-term uptrend.
   * **Delta_Previous_Relative_Divergence:** -4.11 - The negative value indicates a recent short-term downtrend in the stock's price. 
   * **Expected_Return:** 15.04% - This represents the potential maximum return over the next 5 years based on current investment levels. 

4. **Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-05 | 2.15 | 16.11 B$ |
| 2024-05-03 | 1.88 | 15.78 B$ |
| 2023-11-03 | 1.87 | 15.96 B$ |
| 2023-08-07 | -2.35 | 15.04 B$ |
| 2024-08-05 | -2.35 | 15.04 B$ |

* **Analysis:** MRK's recent earnings have shown a consistent growth trend, with the latest quarter exceeding analysts' expectations. This suggests that the company is performing well, despite the overall market volatility. 

**Overall Analysis:**

While MRK has lagged behind the S&P 500 in terms of overall performance, its recent earnings and technical indicators suggest potential for short-term growth.  The stock is currently in neutral territory with a potential for a rebound, but investors should keep an eye on the market conditions and observe the stock's future performance to determine its long-term prospects. 
